secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2023-10-06T23:59:59+00:00
Accession:  0001493152-23-036495
Event type: debt
Sentiment:  neutral
Materiality: 0.40
Item codes: 2.03, 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AgeX Therapeutics draws $500,000 under Secured Convertible Note with Juvenescence Limited
--------------------------------------------------------------------------------

- Drew $500,000 on Oct 3, 2023 from existing Amended Secured Convertible Note with Juvenescence Limited.
- Repayment of principal due February 14, 2024; terms unchanged from prior filings.
- Material terms previously detailed in May 2023 10-Q and June/August 2023 8-Ks.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223036495/0001493152-23-036495-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223036495/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-036495

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer